The Current Ratio as of November 2024 (TTM) for Precision BioSciences, Inc. (DTIL) is 9.22

According to Precision BioSciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.22. This represents a change of 74.48% compared to the average of 5.29 of the last 4 quarters.

Precision BioSciences, Inc. (DTIL) Historical Current Ratio (quarterly & annually)

How has DTIL Current Ratio performed in the past?

The mean historical Current Ratio of Precision BioSciences, Inc. over the last ten years is 5.84. The current 9.22 Current Ratio has changed 15.69% with respect to the historical average. Over the past ten years (40 quarters), DTIL's Current Ratio was at its highest in in the June 2019 quarter at 14.99. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Precision BioSciences, Inc. (DTIL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Precision BioSciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Precision BioSciences, Inc. (DTIL) Average Current Ratio

How has DTIL Current Ratio performed in the past?

The current Current Ratio of Precision BioSciences, Inc. (DTIL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Precision BioSciences, Inc. (DTIL) Current Ratio vs. Peers

How is DTIL’s Current Ratio compared to its peers?

Precision BioSciences, Inc.’s Current Ratio is greater than X4 Pharmaceuticals, Inc. (4.89), less than Acumen Pharmaceuticals, Inc. (10.43), greater than Inozyme Pharma, Inc. (7.68), less than Terns Pharmaceuticals, Inc. (32.99), less than Day One Biopharmaceuticals, Inc. (14.62), greater than Eledon Pharmaceuticals, Inc. (6.53), greater than HOOKIPA Pharma Inc. (3.26), greater than Mereo BioPharma Group plc (6.10), greater than Galera Therapeutics, Inc. (5.63), greater than Passage Bio, Inc. (5.15), greater than Black Diamond Therapeutics, Inc. (5.55), greater than TCR2 Therapeutics Inc. (2.77), greater than Harpoon Therapeutics, Inc. (1.89), greater than Alector, Inc. (3.29), greater than Stoke Therapeutics, Inc. (5.09), less than Pliant Therapeutics, Inc. (10.26), less than Dyne Therapeutics, Inc. (17.02), less than Cytokinetics, Incorporated (9.28), less than Revolution Medicines, Inc. (14.24),

Build a custom stock screener for Precision BioSciences, Inc. (DTIL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precision BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Precision BioSciences, Inc. (DTIL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Precision BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.